The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways-Reference-Cited by-同舟云学术

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

Published:2003-05-15 Issue:3 Volume:306 Page:954-964
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Millan M. J.,Gobert A.,Lejeune F.,Dekeyne A.,Newman-Tancredi A.,Pasteau V.,Rivet J.-M.,Cussac D.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference54 articles.

1. Aghajanian GK and Bunney BS (1973) Central dopaminergic neurons: neurophysiological identification and response to drugs, in Frontiers of Catecholamine Research (Usdin E and Snyder SH eds) pp 643-648, Pergamon Press, New York.

2. Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons

3. Agonist-induced GTPγ35S binding mediated by human 5-HT2C receptors expressed in human embryonic kidney 293 cells

4. Catecholamine regulation of the prefrontal cortex

Cited by 445 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agomelatine: pharmacological profile, possible application, advantages;Neurology, Neuropsychiatry, Psychosomatics;2024-08-22

2. Relationship Between Melatonin Receptor Agonists and Parkinson's Disease;Journal of Pineal Research;2024-08

3. Isolation, characterization and therapeutic potential of a novel furanoid diterpene lactone from Hedychium spicatum rhizomes: Insights into antioxidant, anxiolytic, and circadian rhythm modulating properties;Phytomedicine Plus;2024-08

4. Circadian disruptions and brain clock dysregulation in mood disorders;Nature Mental Health;2024-07-11

5. DSP-6745, a novel 5-hydroxytryptamine modulator with rapid antidepressant, anxiolytic, antipsychotic and procognitive effects;Psychopharmacology;2024-06-10